BROOKE MCAFEE: Open Payments
NPI 1558928226 · LOUISVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$168 in 9 payments from 7 companies in 2025. Trend: 2023 $142 · 2024 $246 · 2025 $168
Food & beverage: $168
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 2 | $50 |
| Sumitomo Pharma America, Inc. | 2 | $32 |
| Biogen, Inc. | 1 | $25 |
| Bracco Diagnostics Inc. | 1 | $22 |
| Amgen Inc. | 1 | $18 |
| Novo Nordisk Inc | 1 | $17 |
| MAYNE PHARMA COMMERCIAL LLC | 1 | $5 |
Products named: Veozah, MYFEMBREE, ZURZUVAE, Vueway (gadopiclenol), EVENITY, Wegovy.
Industry payments across KY — which companies pay providers there.
